Renowned NET specialist Dr. Dan Granberg, will be available for patient consult with Dr. Eric Liu at Rocky Mountain Cancer Centers in Denver, CO Feb 26-28, 2018, underwritten by a donor advised fund from The Healing NET Foundation.
Appointments can be booked now through Lisa Quesada at Rocky Mountain Cancer Centers. firstname.lastname@example.org 303-388-4876
Background on European Physician Exchange: Many of the treatments now being approved in the U. S. have been in use in Europe for many years. European experts who have been engaged in research and clinical treatment can shorten the learning curve for North American physicians through ongoing mentoring, speaking at meetings, and consultations with patients. The European Physician Exchange program is underwritten through a donor advised fund by the Healing NET Foundation (HNF) and is currently offered at the Rocky Mountain Cancer Centers in Denver, CO. HNF sponsored Dr. Kjell Oberg in 2016.
Dan Granberg, MD, PhD BIO
Associate Professor, Senior Consultant, Department of Endocrine Oncology
Dr. Granberg is a world-renowned physician and a consultant at the Department of Endocrine Oncology, Uppsala Centre of Excellence for endocrine tumors. He is a leading carcinoid and neuroendocrine cancer specialist and has extensive experience in endocrine oncology. His clinical interests are in endocrine tumors, diagnostic procedures, medical therapy, peptide receptor radionuclide therapy, and radioembolization. His research efforts focus on bronchial carcinoids, thymic carcinoids, and development of new diagnostic and therapeutic methods. He has also given many lectures to medical students, doctors, and patients in Sweden and in other countries. He is responsible for the PRRT program with Lutetium-Octreotate at the Department of Endocrine Oncology. He serves as an honorary reviewer for the Journal of Molecular and Genetic Medicine. In addition, he has published more than 50 peer-reviewed articles and reviews, and is the author of a number of book chapters on bronchial carcinoids and NETs. He is currently involved in several research projects in the field of NETs, and is the principal investigator in several clinical trials.